VIR Q1 2022 Earnings — Vir Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

VIRVir Biotechnology, Inc.

$1B

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.2B+203612.2% YoY

Gross Profit

$1.1B85.4% margin

Operating Income

$1.0B82.3% margin

Net Income

$519M42.1% margin

EPS (Diluted)

$3.85

QoQ Revenue Growth

+51.6%

Cash Flow

Operating Cash Flow

$550M

Free Cash Flow

$534M

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$2.9B

Total Liabilities

$886M

Stockholders' Equity

$2.0B

Cash & Equivalents

$812M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$605,000	+203612.2%
Gross Profit	$1.1B	$605,000	+173798.0%
Operating Income	$1.0B	-$159M	+739.1%
Net Income	$519M	-$169M	+407.0%

Revenue Segments

Collaboration Revenue

$1.2B100%

Contract Revenue

$282,0000%